Bioray Biotech Co., Ltd (TPEX:7561)
Taiwan · Delayed Price · Currency is TWD 20.10
-0.80 (-3.83%)
Jan 8, 2026, 11:34 AM CST
Bioray Biotech Revenue
Bioray Biotech had revenue of 115.92M TWD in the half year ending December 31, 2024, with 13.94% growth. This brings the company's revenue in the last twelve months to 230.06M, up 25.32% year-over-year. In the year 2024, Bioray Biotech had annual revenue of 201.71M with 5.15% growth.
Revenue (ttm)
230.06M
Revenue Growth
+25.32%
P/S Ratio
2.58
Revenue / Employee
n/a
Employees
n/a
Market Cap
594.66M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 201.71M | 9.88M | 5.15% |
| Dec 31, 2023 | 191.83M | 1.23M | 0.65% |
| Dec 31, 2022 | 190.60M | 42.58M | 28.77% |
| Dec 31, 2021 | 148.02M | -8.28M | -5.30% |
| Dec 31, 2020 | 156.30M | -25.64M | -14.09% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Bora Pharmaceuticals Co., LTD. | 21.10B |
| Lotus Pharmaceutical | 18.66B |
| PharmaEssentia | 13.82B |
| Pegavision | 6.90B |
| Center Laboratories | 1.57B |
| Oneness Biotech | 117.33M |
| Polaris Group | 70.83M |
| Lumosa Therapeutics | 42.59M |